KR20110056536A - 프람린티드의 제조 방법 - Google Patents

프람린티드의 제조 방법 Download PDF

Info

Publication number
KR20110056536A
KR20110056536A KR1020117007671A KR20117007671A KR20110056536A KR 20110056536 A KR20110056536 A KR 20110056536A KR 1020117007671 A KR1020117007671 A KR 1020117007671A KR 20117007671 A KR20117007671 A KR 20117007671A KR 20110056536 A KR20110056536 A KR 20110056536A
Authority
KR
South Korea
Prior art keywords
tbu
trt
asn
peptide
formula
Prior art date
Application number
KR1020117007671A
Other languages
English (en)
Korean (ko)
Inventor
쩡 유 시아오
진 구오 딩
Original Assignee
시노팜 타이완 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시노팜 타이완 리미티드 filed Critical 시노팜 타이완 리미티드
Publication of KR20110056536A publication Critical patent/KR20110056536A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020117007671A 2008-09-03 2009-09-03 프람린티드의 제조 방법 KR20110056536A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19092808P 2008-09-03 2008-09-03
US61/190,928 2008-09-03

Publications (1)

Publication Number Publication Date
KR20110056536A true KR20110056536A (ko) 2011-05-30

Family

ID=41726391

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020117007671A KR20110056536A (ko) 2008-09-03 2009-09-03 프람린티드의 제조 방법
KR1020117007669A KR101634830B1 (ko) 2008-09-03 2009-09-03 비발리루딘의 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020117007669A KR101634830B1 (ko) 2008-09-03 2009-09-03 비발리루딘의 제조방법

Country Status (11)

Country Link
US (2) US8252896B2 (zh)
EP (2) EP2349307B1 (zh)
JP (2) JP5788321B2 (zh)
KR (2) KR20110056536A (zh)
CN (2) CN102164608A (zh)
AR (2) AR073544A1 (zh)
AU (2) AU2009288036A1 (zh)
CA (2) CA2736126C (zh)
IL (2) IL211556A0 (zh)
TW (2) TWI395752B (zh)
WO (2) WO2010028122A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005023429D1 (de) 2004-10-19 2010-10-21 Lonza Ag Verfahren zur festphasen-peptidsynthese
WO2009003666A1 (en) * 2007-06-29 2009-01-08 Lonza Ag Process for the production of pramlintide
ES2439502T3 (es) * 2008-12-29 2014-01-23 Lonza Braine Sa Proceso para la producción de bivalirudina
CN102180943A (zh) * 2010-12-16 2011-09-14 深圳市健元医药科技有限公司 一种辅助降血糖多肽药物的生产工艺
WO2013042129A1 (en) 2011-09-23 2013-03-28 Natco Pharma Limited Improved process for preparation of bivalirudin
WO2014032257A1 (zh) * 2012-08-30 2014-03-06 深圳翰宇药业股份有限公司 一种比伐卢定的制备方法
MX365465B (es) 2013-03-21 2019-06-04 Sanofi Aventis Deutschland Sintesis de productos peptidicos que contienen imida ciclica.
SG11201506804VA (en) 2013-03-21 2015-09-29 Sanofi Aventis Deutschland Synthesis of hydantoin containing peptide products
CN104861045A (zh) * 2014-02-20 2015-08-26 复旦大学 环肽化合物gg6f及其制备方法
WO2020152246A1 (en) * 2019-01-24 2020-07-30 Dsm Ip Assets B.V. Peptide precipitation method
CN111499719B (zh) * 2020-03-19 2022-04-08 杭州固拓生物科技有限公司 一种合成普兰林肽的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240913A (en) 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
US5196404B1 (en) 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
WO1992015317A1 (en) 1991-03-08 1992-09-17 Amylin Pharmaceuticals, Inc. Synthetic preparation of amylin and amylin analogues
GB9708918D0 (en) 1997-05-01 1997-06-25 Ppl Therapeutics Scotland Ltd Methods
US6821954B2 (en) * 1997-09-18 2004-11-23 Auckland Uniservices Limited Compounds and uses thereof in treating bone disorders
BR9909018A (pt) * 1998-03-23 2001-10-16 Trimeris Inc Processo para a sìntese de um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo
DE602005023429D1 (de) 2004-10-19 2010-10-21 Lonza Ag Verfahren zur festphasen-peptidsynthese
AU2005298840B2 (en) * 2004-10-26 2010-09-16 Lonza Ag S-alkyl-sulphenyl protection groups in solid-phase synthesis
MX2008003552A (es) * 2005-09-14 2008-11-12 Novetide Ltd Proceso para la produccion de bivalirudina.
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
CN101033249B (zh) 2006-03-10 2011-05-11 周逸明 固相多肽合成比筏芦定的制备方法
EP2057183A2 (en) 2007-03-01 2009-05-13 Novetide Ltd. High purity peptides
WO2009003666A1 (en) * 2007-06-29 2009-01-08 Lonza Ag Process for the production of pramlintide
US20090062511A1 (en) 2007-09-05 2009-03-05 Raghavendracharyulu Venkata Palle Process for the preparation of bivalirudin and its pharmaceutical compositions
ES2439502T3 (es) * 2008-12-29 2014-01-23 Lonza Braine Sa Proceso para la producción de bivalirudina

Also Published As

Publication number Publication date
WO2010028131A1 (en) 2010-03-11
AR073360A1 (es) 2010-11-03
CA2736113A1 (en) 2010-03-11
EP2349307A4 (en) 2012-03-21
IL211555A0 (en) 2011-05-31
TWI395752B (zh) 2013-05-11
EP2349307B1 (en) 2015-03-04
JP2012502045A (ja) 2012-01-26
IL211556A0 (en) 2011-05-31
TW201014867A (en) 2010-04-16
KR101634830B1 (ko) 2016-06-29
US20100056755A1 (en) 2010-03-04
AU2009288027A2 (en) 2011-11-03
US20100081788A1 (en) 2010-04-01
IL211555A (en) 2014-07-31
AU2009288027B2 (en) 2014-01-16
CN102164608A (zh) 2011-08-24
CA2736126C (en) 2016-11-29
WO2010028122A1 (en) 2010-03-11
TW201024316A (en) 2010-07-01
AR073544A1 (es) 2010-11-17
AU2009288036A2 (en) 2011-09-08
CN102164609A (zh) 2011-08-24
JP5788321B2 (ja) 2015-09-30
CA2736126A1 (en) 2010-03-11
US8252896B2 (en) 2012-08-28
KR20110069048A (ko) 2011-06-22
JP2012502044A (ja) 2012-01-26
EP2334314A4 (en) 2012-03-21
AU2009288027A1 (en) 2010-03-11
WO2010028122A8 (en) 2014-11-13
EP2334314A1 (en) 2011-06-22
AU2009288036A1 (en) 2010-03-11
EP2349307A1 (en) 2011-08-03

Similar Documents

Publication Publication Date Title
KR20110056536A (ko) 프람린티드의 제조 방법
US7348404B2 (en) Solid-phase peptide synthesis and agent for use in such synthesis
CA3017926A1 (en) Methods for synthesizing .alpha.4.beta.7 peptide antagonists
KR20100036326A (ko) 프람린타이드의 생산 방법
EP3765488A1 (en) Process for the manufacture of pthrp analogue
US20110288235A1 (en) Process for the Preparation of Pramlintide
KR20210141600A (ko) 글루카곤 유사 펩티드-1(glp-1) 수용체 작용제 및 이의 유사물의 제조 방법
CN114401981A (zh) 胰高血糖素制造方法
CN105408344B (zh) 肽-树脂结合物及其用途
JP2022527041A (ja) プレカナチドを製造する改善された方法
US9150615B2 (en) Process for the preparation of leuprolide and its pharmaceutically acceptable salts
EP3753946A1 (en) Improved process for the preparation of high purity glucagon
WO2017138855A1 (en) Method for preparation of liraglutide using bal linker
EP2373685A1 (en) Process for preparing therapeutic peptide
US7176282B1 (en) Solid-phase peptide synthesis and agent for use in such synthesis
EP3196207A1 (en) Method for preparation of peptides with pswang linker
CN114945580B (zh) 用于合成南吉博肽的方法
CA1339631C (en) Process and intermediates for grf peptide
WO2019095592A1 (zh) 一种Reltecimod的液相制备方法
Cavallaro et al. Solid‐phase synthesis of a dendritic peptide related to a retinoblastoma protein fragment utilizing a combined boc‐and fmoc‐chemistry approach
CN115433266A (zh) 一种特立帕肽的固相合成方法
WO2011095989A2 (en) An improved process for the preparation of enfuvirtide
WO2019218382A1 (zh) 一种含丙氨酸的首尾环肽合成方法
EP3205660A1 (en) Method for preparation of peptides with pswang linker

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid